These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 16870442

  • 1. Selectively guanidinylated derivatives of neamine. Syntheses and inhibition of anthrax lethal factor protease.
    Jiao GS, Simo O, Nagata M, O'Malley S, Hemscheidt T, Cregar L, Millis SZ, Goldman ME, Tang C.
    Bioorg Med Chem Lett; 2006 Oct 01; 16(19):5183-9. PubMed ID: 16870442
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Mixed-type noncompetitive inhibition of anthrax lethal factor protease by aminoglycosides.
    Kuzmic P, Cregar L, Millis SZ, Goldman M.
    FEBS J; 2006 Jul 01; 273(13):3054-62. PubMed ID: 16817854
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Cationic polyamines inhibit anthrax lethal factor protease.
    Goldman ME, Cregar L, Nguyen D, Simo O, O'Malley S, Humphreys T.
    BMC Pharmacol; 2006 Jun 08; 6():8. PubMed ID: 16762077
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Anthrax lethal factor protease inhibitors: synthesis, SAR, and structure-based 3D QSAR studies.
    Johnson SL, Jung D, Forino M, Chen Y, Satterthwait A, Rozanov DV, Strongin AY, Pellecchia M.
    J Med Chem; 2006 Jan 12; 49(1):27-30. PubMed ID: 16392787
    [Abstract] [Full Text] [Related]

  • 12. Novel small-molecule inhibitors of anthrax lethal factor identified by high-throughput screening.
    Schepetkin IA, Khlebnikov AI, Kirpotina LN, Quinn MT.
    J Med Chem; 2006 Aug 24; 49(17):5232-44. PubMed ID: 16913712
    [Abstract] [Full Text] [Related]

  • 13. Proteolytic assay-based screening identifies a potent inhibitor of anthrax lethal factor.
    Park HC, Sung SR, Lim SM, Lee JS, Kim SK, Yoon MY.
    Microb Pathog; 2012 Aug 24; 53(2):109-12. PubMed ID: 22561400
    [Abstract] [Full Text] [Related]

  • 14. Yeast-hybrid based high-throughput assay for identification of anthrax lethal factor inhibitors.
    Kim J, Park HC, Gedi V, Park HY, Roberts AG, Atkins WM, Yoon MY.
    Biochem Biophys Res Commun; 2011 Jan 07; 404(1):517-22. PubMed ID: 21144836
    [Abstract] [Full Text] [Related]

  • 15. Rhodanine derivatives as selective protease inhibitors against bacterial toxins.
    Johnson SL, Chen LH, Harbach R, Sabet M, Savinov A, Cotton NJ, Strongin A, Guiney D, Pellecchia M.
    Chem Biol Drug Des; 2008 Feb 07; 71(2):131-9. PubMed ID: 18221310
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The cytotoxic activity of Bacillus anthracis lethal factor is inhibited by leukotriene A4 hydrolase and metallopeptidase inhibitors.
    Menard A, Papini E, Mock M, Montecucco C.
    Biochem J; 1996 Dec 01; 320 ( Pt 2)(Pt 2):687-91. PubMed ID: 8973585
    [Abstract] [Full Text] [Related]

  • 18. Examination of anthrax lethal factor inhibition by siderophores, small hydroxamates, and protamine.
    Thomas M, Castignetti D.
    J Microbiol Immunol Infect; 2009 Aug 01; 42(4):284-9. PubMed ID: 19949750
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.